INTANGIBLE ASSETS (Narrative) (Details) - Intellectual property [Member] $ in Millions	12 Months Ended
Dec. 31, 2023 USD ($)
Agalimmune Ltd. [Member]
Disclosure of detailed information about intangible assets [line items]
Intangible assets acquired	$ 6.7
Biokine Therapeutics Ltd [Member]
Disclosure of detailed information about intangible assets [line items]
Intangible assets acquired	$ 15.0
Percentage of payment to be made	40% to 20%

The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B64
-Subparagraph i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph IE72
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_IE72&doctype=Illustrative%20Examples
-URIDate 2023-03-23

Name:	ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant